Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C
- 1 November 2000
- journal article
- case report
- Published by Elsevier in Journal of Hepatology
- Vol. 33 (5) , 812-817
- https://doi.org/10.1016/s0168-8278(00)80314-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Therapy of hepatitis C: Alpha interferon and ribavirinHepatology, 1997
- Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trialHepatology, 1997
- Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled studyJournal of Hepatology, 1996
- Ribavirin as Therapy for Chronic Hepatitis CAnnals of Internal Medicine, 1995
- Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis CJournal of Medical Virology, 1993
- Molecular Mechanisms of Action of RibavirinClinical Infectious Diseases, 1990
- Broad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamideScience, 1972